D2OC34 Stock Overview
Operates a cloud-based digital platform for medical professionals in the United States. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Doximity, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$56.75 |
52 Week High | US$60.30 |
52 Week Low | US$19.99 |
Beta | 1.38 |
1 Month Change | 4.13% |
3 Month Change | 42.37% |
1 Year Change | 152.45% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 32.62% |
Recent News & Updates
Recent updates
Shareholder Returns
D2OC34 | BR Healthcare Services | BR Market | |
---|---|---|---|
7D | -4.6% | 0% | 0% |
1Y | 152.4% | 0% | 0% |
Return vs Industry: D2OC34 exceeded the BR Healthcare Services industry which returned 5.9% over the past year.
Return vs Market: D2OC34 exceeded the BR Market which returned -13.6% over the past year.
Price Volatility
D2OC34 volatility | |
---|---|
D2OC34 Average Weekly Movement | 12.6% |
Healthcare Services Industry Average Movement | 0% |
Market Average Movement | 0% |
10% most volatile stocks in BR Market | 0% |
10% least volatile stocks in BR Market | 0% |
Stable Share Price: D2OC34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine D2OC34's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | 827 | Jeff Tangney | www.doximity.com |
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company’s platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. It primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems.
Doximity, Inc. Fundamentals Summary
D2OC34 fundamental statistics | |
---|---|
Market cap | R$61.85b |
Earnings (TTM) | R$1.08b |
Revenue (TTM) | R$3.20b |
59.2x
P/E Ratio19.9x
P/S RatioIs D2OC34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
D2OC34 income statement (TTM) | |
---|---|
Revenue | US$516.85m |
Cost of Revenue | US$51.98m |
Gross Profit | US$464.87m |
Other Expenses | US$290.76m |
Earnings | US$174.11m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.93 |
Gross Margin | 89.94% |
Net Profit Margin | 33.69% |
Debt/Equity Ratio | 0% |
How did D2OC34 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/03 05:03 |
End of Day Share Price | 2025/01/03 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Doximity, Inc. is covered by 25 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Vikram Kesavabhotla | Baird |
Nisala Weerasuriya | Berenberg |
Allen Lutz | BofA Global Research |